- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06489314
Mental Health Treatment to Improve Father Depression and Child Outcomes in Kenya
A Brief, Task-shifted Treatment to Improve Father Depression and Child Outcomes in Kenya: A Pilot Effectiveness-implementation Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Investigators will conduct a pilot randomized control trial using an implementation-effectiveness Hybrid Type I design. Fathers with depression (n=102) will be randomized to depression treatment LEAD or a wait list (WL) control at a rate of 2:1. LEAD will be offered to the WLC following treatment. This is a pilot. Aims focus on preliminary indicators of effectiveness and feasibility and acceptability (implementation). Data will inform a larger trial.
The objective of this study is to conduct a pilot randomized control trial using an implementation-effectiveness Hybrid Type I design to explore improvements in father depression using a brief, task-shifted intervention and explore implementation feasibility and acceptability. Participants will be randomized to LEAD (Learn, Act, Engage, Dedicate), a 5-session behavioral activation and motivational interviewing treatment, or to a waitlist control group (WL) in Eldoret, Kenya among men with depression symptoms (WL participants will be offered treatment at their final assessment). Fathers (n=102) will be randomized to treatment at a rate of 2:1; assessments will occur at baseline, post treatment, and 1 and 3 months post. As part of Aim 1, investigators will explore changes between groups in father depression post-treatment as measured by the PHQ-9, as well as secondary outcomes of drinking, parenting, interparental problems, and child mental health assessed among men, a co-caregiver, and one child with surveys (Women (n=102) and children (n=102) will only report on themselves and family outcomes not father mental health). The WL will receive all assessments at each timepoint and be monitored for safety; rates of attrition will be tracked throughout as well as rates of those possibly pursuing care during the trial. Next, investigators will explore potential mechanisms of change on father depression and family and child outcomes using survey measures as well as qualitative data - both semi-structured interviews 1 month post with men and family participants (n=30) and transcript analysis (n=20) of men and families showing different patterns of response or non-response. Lastly, investigators will explore implementation feasibility and acceptability as measured by qualitative interviews assessing acceptability and barriers/facilitators to delivery, including social determinant barriers such as economic hardship, and brief surveys with providers 1-month after treatment, as well as fidelity (adherence to intervention steps), coded from 20% of randomly selected session transcripts based on a previously developed and piloted adherence tool, and participant retention and attendance.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Eldoret, Kenya, 30100
- Moi Teaching and Referral Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male between the ages of 18-65;
- Live with and be responsible for at least one child between the ages of 8 and 17 years of age;
- Screen positive for depression symptoms, operationalized as a score above 5 on the patient health questionnaire (PHQ-9);
- Any reported alcohol use in the past 45 days measures with the AUDIT (score 1 or above);
- Child at risk of mental health issues as indicated by a score above 13 on the Strengths and Difficulties Questionnaire (SDQ) reported on by any caregiver;
- Willingness for co-caregiver and target child to participate in assessments (previously piloted strategy).
Exclusion Criteria:
- Severe depression symptoms indicated a score above 19 on the PHQ-9;
- Severe risk/likely alcohol dependence that warrants medical management indicated as a score 20 or above on the alcohol use disorder identification test (AUDIT);
- Violent legal offenses (one question);
- Indicators of severe violence at home assessed with key items from the Conflict Tactics Scale (CTS), following previously used criteria. If any couple member answers yes (related to the father) to either of the following items: "punched or hit my partner with something that could hurt" and "kicked my partner," couples will be excluded. Couple members who answer yes to any of the following items: "I/he used a knife or gun on my partner/me," "I/he choked my partner/me," "I/he slammed my partner/me against a wall," "I/he beat up my partner/me," "I/he burned or scalded my partner/me on purpose," will be excluded.
- Inability to provide informed consent of complete procedures in Swahili or English;
- serious mental illness (current or history).
- Youth in age range not at risk for MH problems: No Score <13 to 40 on the SDQ as reported by both caregivers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LEAD Intervention
LEAD consists of behavioral activation (BA) and motivational interviewing (MI), as well as discussions of masculinity and a family focus throughout to target father's depression symptoms and common comorbidities, like drinking.
LEAD is guided by a manual (in Swahili and English).
It includes five, 60-90-minute weekly sessions.
LEAD was adapted for context based on formative work.
Each session begins with MH assessment and review of activity completion and ends with homework to monitor activities.
LEAD uses MI strategies to engage men in the treatment and increase commitment to addressing problems.
MI strategies are then integrated throughout.
(Session 1-5) to enhance father motivation to complete activities as well as to build self-efficacy (e.g., when reviewing homework, peer-father counselors reflect successes).
|
LEAD is a 5-session behavioral activation (BA) intervention delivered by peer-father counselors.
LEAD also incorporates motivational interviewing (MI) and masculinity discussion strategies.
This is a task-shifted intervention meaning mental health service tasks are delegated to non-specialist providers, in this case peer-fathers, as opposed to a specialized workforce (e.g., psychiatrists, psychologists).
|
|
No Intervention: Waitlist Control
Those randomized to WL will complete assessments and be monitored at each timepoint; they will be offered LEAD following the last assessment.
In a pilot, a control allows for a realistic examination of recruitment, randomization, implementation of LEAD, assessment procedures, and retention.
If safety concerns arise, referrals and safety procedures will be implemented.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression Symptoms
Time Frame: Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Patient Health Questionnaire (PHQ-9): a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression, previously validated and used in Kenya.
|
Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Type of Alcohol Use
Time Frame: Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
AUDIT (Alcohol Use Disorders Identification Test): a simple and effective method of screening for unhealthy alcohol use, defined as risky or hazardous consumption or any alcohol use disorder.
The AUDIT has been has been previously validated in Kenya.
|
Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
|
Gender Norms
Time Frame: Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Gender-Equitable Men (GEM) Scale: assesses men's beliefs about gender norms and gender roles.
Higher scores correspond with more equitable gender views.
This scale has been previously used in Kenya to measure inequitable attitudes
|
Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
|
Disrupted Parenting
Time Frame: Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Alabama Parenting Questionnaire (APQ - Father Involvement Scale) (Adapted): The involvement subscale of the Alabama Parenting Questionnaire (APQ) assesses father level of participation in their child's life, such as father attendance at child activities or help with homework.
Items have been adapted to enhance local acceptability, understandability, and completeness with minor adaptations and previously piloted in Eldoret, Kenya.
|
Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
|
Interparental Problems
Time Frame: Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Family Togetherness Scale (FTS): Interparental problems will be assessed with 25 items, such as "How often does your family have quarrels?"
Items relate to issues of family structure, couple emotional climate, and couple communication.
These items were locally developed (Puffer et al., 2018), and have been validated in the context.
Scores are averaged by reporter (men reliability = 0.95; co-caregivers reliability = 0.96; Child reliability = 0.95), with higher scores indicating poorer family functioning in this study.
|
Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
|
Child Mental Health
Time Frame: Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Strengths and Difficulties Questionnaire (SDQ): The Strengths and Difficulties Questionnaire (SDQ) is a 25 item brief youth mental health screening questionnaire relevant to 3 to 17 year olds that has been validated for both caregiver and youth report.
The measures assesses emotional symptoms (5 items); 2) conduct problems (5 items) ; 3) hyperactivity/inattention (5 items) ; 4) peer relationship problems (5 items); 5) prosocial behavior (5 items), as well as a total score (20 items.
We will use the total item score.
The SDQ has previously used in Kenya and Eldoret with good performance.
|
Baseline (Time point 1, in year 1); 6-10 weeks after baseline; 10-14 weeks after baseline; 19-23 weeks after baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Engagement
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
engagement is defined as the percent of participant attendance these are sessions attended as scheduled or rescheduled.
This will be tracked and logged by RA during treatment.
|
through the treatment period, 2- 8 weeks after baseline
|
|
Activity Completion
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
RA's will code participants activity schedules that they complete as part of their treatment homework.
Homework consists of scheduling activities that are pleasant, healthy or aligned with values.
Schedules will be coded as the the percentage of positive activities they indicted that they would complete in the previous session as well as the frequency activities completed.
|
through the treatment period, 2- 8 weeks after baseline
|
|
Positive Emotional Reinforcement
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
Positive emotion or positive reinforcement following activity completion will be assessed through the activities schedules completed as part of intervention homework.
When reviewing homework in session, patient and counselor will discuss and write down the emotion felt after completing a scheduled activity.
These schedules will coded by RA's following each treatment session for patient's report of what activities they completed and the emotion felt immediately after the completed activity.
Emotions will be coded as 'positive' (e.g., proud, relief, mastery, pleasurable) or 'not positive' (e.g., boring, angry, frustrated) resulting in the percentage of positive emotion of completed activities.
|
through the treatment period, 2- 8 weeks after baseline
|
|
Fidelity Checklist
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
All intervention sessions will be audiotaped; 20 percent of tapes will be transcribed, translated to English, and then reviewed by the PI and project coordinator.
Fidelity ratings will be based on a previously piloted assessment of adherence and competency.
A "fidelity score" will be calculated based on the proportion of key intervention components delivered as intended across sessions (Yes/No) as well as quality of delivery (1-4, 4 excellent).
|
through the treatment period, 2- 8 weeks after baseline
|
|
Retention
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
retention will be analyzed as the percentage of fathers: attending one session or more session, attending 75 percent of session or more, and those who dropped out of LEAD
|
through the treatment period, 2- 8 weeks after baseline
|
|
Participation
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
analyzed as the percentage of fathers who enroll in LEAD who are eligible and percent excluded due to ineligibility
|
through the treatment period, 2- 8 weeks after baseline
|
|
Feasibility of the Intervention and Implementation
Time Frame: 6-10 weeks after baseline
|
4-item feasibility of intervention measure.
Scale 1-5 completely disagree to completely agree.
|
6-10 weeks after baseline
|
|
Acceptability (quantitative)
Time Frame: 6-10 weeks after baseline
|
4-item acceptability of intervention measure.
Scale 1-5 completely disagree to completely agree.
|
6-10 weeks after baseline
|
|
Appropriateness
Time Frame: 6-10 weeks after baseline
|
4-item measures assessing intervention appropriateness .
Scale 1-5 completely disagree to completely agree.
|
6-10 weeks after baseline
|
|
General Counseling Competency
Time Frame: through the treatment period, 2- 8 weeks after baseline
|
General clinical competency will be coded and rated using a previously adapted and piloted version of the ENhancing Assessment of Common Therapeutic factors (ENACT) rating scale using session recordings.
|
through the treatment period, 2- 8 weeks after baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ali Giusto, PhD, Florida International University
Publications and helpful links
General Publications
- Kohrt BA, Jordans MJ, Rai S, Shrestha P, Luitel NP, Ramaiya MK, Singla DR, Patel V. Therapist competence in global mental health: Development of the ENhancing Assessment of Common Therapeutic factors (ENACT) rating scale. Behav Res Ther. 2015 Jun;69:11-21. doi: 10.1016/j.brat.2015.03.009. Epub 2015 Mar 24.
- Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45. doi: 10.1097/00004583-200111000-00015.
- Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, Omollo O, Yebei VN, Ojwang C. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med. 2009 Feb;24(2):189-97. doi: 10.1007/s11606-008-0846-z. Epub 2008 Nov 20.
- Puffer ES, Healy EF, Green EP, Giusto AM, Kaiser BN, Patel P, Ayuku D. Family Functioning and Mental Health Changes Following a Family Therapy Intervention in Kenya: a Pilot Trial. J Child Fam Stud. 2020 Dec;29(12):3493-3508. doi: 10.1007/s10826-020-01816-z. Epub 2020 Sep 24.
- Puffer ES, Giusto A, Rieder AD, Friis-Healy E, Ayuku D, Green EP. Development of the Family Togetherness Scale: A Mixed-Methods Validation Study in Kenya. Front Psychol. 2021 Jun 8;12:662991. doi: 10.3389/fpsyg.2021.662991. eCollection 2021.
- Vreeman RC, Scanlon ML, Marete I, Mwangi A, Inui TS, McAteer CI, Nyandiko WM. Characteristics of HIV-infected adolescents enrolled in a disclosure intervention trial in western Kenya. AIDS Care. 2015;27 Suppl 1(sup1):6-17. doi: 10.1080/09540121.2015.1026307.
- Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B. & Monteiro, M. G. Audit. The Alcohol Use Disorders Identification Test (AUDIT): guidelines for use in primary care (2001)
- Pulerwitz, J. & Barker, G. Measuring Attitudes toward Gender Norms among Young Men in Brazil: Development and Psychometric Evaluation of the GEM Scale. Men and Masculinities 10, 322-338 (2007).
- Essau, C. A., Sasagawa, S. & Frick, P. J. Psychometric properties of the Alabama parenting questionnaire. Journal of Child and Family Studies 15, 595-614 (2006).
- Giusto A, Jaguga F, Aburi D, Korir M, Maina W, Rono W, Greenlee M. Protocol for a Hybrid-type 1 pilot study of a randomized control trial of a brief, peer-delivered treatment to improve father depression and child mental health in Kenya. PLoS One. 2025 Jun 26;20(6):e0325902. doi: 10.1371/journal.pone.0325902. eCollection 2025.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Drinking Behavior
- Behavior
- Alcohol Drinking
- Depression
- Peptides
- Amino Acids, Peptides, and Proteins
- Proteins
- Carbohydrates
- Blood Proteins
- Serum Globulins
- Globulins
- Inorganic Chemicals
- Socioeconomic Factors
- Population Characteristics
- Elements
- Metals
- Metals, Heavy
- Glycoproteins
- Glycoconjugates
- Acute-Phase Proteins
- Serpins
- Alpha-Globulins
- Educational Status
- Lead
- alpha 1-Antichymotrypsin
Other Study ID Numbers
- 1K23MH128742-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on LEAD (Learn, Engage, Act, Dedicate)
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH)CompletedHIV Prevention | Self Efficacy | STI PreventionUnited States